Jenny Seligmann, Professor of Gastrointestinal Oncology at the University of Leeds, shared a post on LinkedIn:
“FOxTROT 5 testing Péri-operative dostarlimab in MSI-H locally advanced colon cancer in older or frail patients. Also thanks to our fantastic 🇬🇧 investigators.
FOxTROT 6 to follow soon.”
Other articles featuring Jenny Seligmann.